Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Lübbert

Showing results (31-40 of 248) with videos related to

Pageof 25
Sort By:
Oncogene|July 31, 2021
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanismsKai Rejeski, Jesús Duque-Afonso, Michael Lübbert
Cancer|March 15, 2006
Superiority of prolonged low-dose azanucleoside administration? Results of 5-aza-2'-deoxycytidine retreatment in high-risk myelodysplasia patientsBjörn Rüter, Pierre W Wijermans, Michael Lübbert
Journal of Clinical Medicine|August 4, 2015
Clinical Results of Hypomethylating Agents in AML TreatmentMarjan Cruijsen, Michael Lübbert, Pierre Wijermans, et al.
Oncogene|October 19, 2004
Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETOManfred Fliegauf, Michael Stock, Tobias Berg, et al.
Annals of Hematology|November 18, 2005
In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studiesBjörn Hackanson, Christian Robbel, Pierre Wijermans, et al.
International Journal of Cancer|November 29, 2022
Role of Bcl-2 inhibition in myelodysplastic syndromesSabine Blum, Gerasimos Tsilimidos, Helena Bresser, et al.
In Vivo (Athens, Greece)|November 6, 2003
Fatal outcome in a patient with metastatic prostate cancer and acquired severe hypogammaglobulinemia with complete absence of mature peripheral blood B-cellsJens Lohr, Stephan Mielke, Michael Lübbert, et al.
Epigenetics|November 16, 2016
Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectivesInsa Schiffmann, Gabriele Greve, Manfred Jung, et al.
Advances in Therapy|February 16, 2022
Correction to: The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid LeukemiaValeria Santini, Michael Lübbert, Agnieszka Wierzbowska, et al.
Haematologica|December 24, 2002
DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemiasGiuseppe Leone, Luciana Teofili, Maria Teresa Voso, et al.
Pageof 25

Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
Oncogene|July 31, 2021
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanismsKai Rejeski, Jesús Duque-Afonso, Michael Lübbert
Cancer|March 15, 2006
Superiority of prolonged low-dose azanucleoside administration? Results of 5-aza-2'-deoxycytidine retreatment in high-risk myelodysplasia patientsBjörn Rüter, Pierre W Wijermans, Michael Lübbert
Journal of Clinical Medicine|August 4, 2015
Clinical Results of Hypomethylating Agents in AML TreatmentMarjan Cruijsen, Michael Lübbert, Pierre Wijermans, et al.
Oncogene|October 19, 2004
Williams-Beuren syndrome critical region-5/non-T-cell activation linker: a novel target gene of AML1/ETOManfred Fliegauf, Michael Stock, Tobias Berg, et al.
Annals of Hematology|November 18, 2005
In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studiesBjörn Hackanson, Christian Robbel, Pierre Wijermans, et al.
International Journal of Cancer|November 29, 2022
Role of Bcl-2 inhibition in myelodysplastic syndromesSabine Blum, Gerasimos Tsilimidos, Helena Bresser, et al.
In Vivo (Athens, Greece)|November 6, 2003
Fatal outcome in a patient with metastatic prostate cancer and acquired severe hypogammaglobulinemia with complete absence of mature peripheral blood B-cellsJens Lohr, Stephan Mielke, Michael Lübbert, et al.
Epigenetics|November 16, 2016
Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectivesInsa Schiffmann, Gabriele Greve, Manfred Jung, et al.
Advances in Therapy|February 16, 2022
Correction to: The Clinical Value of Decitabine Monotherapy in Patients with Acute Myeloid LeukemiaValeria Santini, Michael Lübbert, Agnieszka Wierzbowska, et al.
Haematologica|December 24, 2002
DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemiasGiuseppe Leone, Luciana Teofili, Maria Teresa Voso, et al.
Pageof 25